Diminished efficacy of bacille Calmette-Guérin among elderly patients with nonmuscle invasive bladder cancer

Diminished efficacy of bacille Calmette-Guérin among elderly patients with nonmuscle invasive bladder cancer

Bibliographic Details
Main Authors:	D Margel, SS Alkhateeb, A Finelli, N Fleshner
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Urologia 2011-10-01
Series:	International Brazilian Journal of Urology
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382011000500031

Similar Items

Combination of Intravesical Bacille Calmette-Guérin and Chemotherapy vs. Bacille Calmette-Guérin Alone in Non-muscle Invasive Bladder Cancer: A Meta-Analysis
by: Di Huang, et al.
Published: (2019-03-01)

Bacille Calmette-Guérin Vaccination and Tuberculosis
by: Nick R Anthonisen
Published: (2005-01-01)

The Use of Bacille Calmette-Guérin vaccination in Children
by: David P Speert
Published: (1995-01-01)

Determinants of Bacille Calmette-Guérin scarification in Danish children
by: Trine Mølbæk Jensen, et al.
Published: (2021-01-01)

Gluteal abscess: An unusual complication of Bacille Calmette-Guérin
by: Hakan Buyukoglan, et al.
Published: (2011-01-01)

Next-Generation Vaccines Based on Bacille Calmette–Guérin
by: Natalie E. Nieuwenhuizen, et al.
Published: (2018-02-01)

Sleeping Beauty and the Story of the Bacille Calmette-Guérin Vaccine
by: Helen A. Fletcher
Published: (2016-08-01)

Disseminated Bacille Calmette-Guérin disease in immunocompetent adult patients
by: Luísa Nascimento, et al.
Published: (2016-07-01)

Mycobacterium bovis Bacille-Calmette-Guérin Infection Aggravates Atherosclerosis
by: Moises A. Huaman, et al.
Published: (2020-12-01)

When the Treatment is the Cause: Disseminated Bacille Calmette–Guérin Infection
by: Ana Teresa Marques Afonso, et al.
Published: (2020-06-01)

Will bacille Calmette-Guerin immunization arrest the COVID-19 pandemic?
by: Nasreen Zafar Ehtesham, et al.
Published: (2020-01-01)

Penile tuberculosis following intravesical Bacille Calmette-Guérin immunotherapy
by: Anadi Roy Chowdhury, et al.
Published: (2013-01-01)

Bacille Calmette-Guérin Supply Disruption Emphasizes the Importance of Stewardship
by: Alejandro Abello, et al.
Published: (2019-09-01)

Bilateral symmetrical corneal melting following intravesical Bacille Calmette-Guerin therapy for bladder carcinoma
by: Chandana Chakraborty, et al.
Published: (2012-01-01)

Post-Bacille Calmette–Guerin surveillance for non-muscle invasive bladder cancer: do random biopsies offer an advantage?
by: Nassib Abou Heidar, et al.
Published: (2021-03-01)

Alternative Therapies to Bacillus Calmette-Guérin Shortage for Nonmuscle Invasive Bladder Cancer in Brazil and Other Underdeveloped Countries: Management Considerations
by: Marcelo Langer Wroclawski, et al.
Published: (2019-08-01)

Editorial comment on “Maintenance bacillus Calmette-Guérin therapy for nonmuscle-invasive bladder cancer: A need for more randomized trials”
by: Shu-Pin Huang
Published: (2015-06-01)

The Recombinant Bacille Calmette–Guérin Vaccine VPM1002: Ready for Clinical Efficacy Testing
by: Natalie E. Nieuwenhuizen, et al.
Published: (2017-09-01)

Imaging appearance of granulomatous disease after intravesical Bacille Calmette-Guerin (BCG) treatment of bladder carcinoma
by: Adilson Prando
Published: (2009-10-01)

Lymphadenitis and lichen scofulosorum following bacille calmette-guérin vaccination in an infant
by: Taru Garg, et al.
Published: (2021-01-01)

Role of Bacille Calmette-Guérin in offering protection against COVID-19
by: Sharad Bagri, et al.
Published: (2020-01-01)

Bacille Calmette-Guérin Vaccination in Saudi Arabia: Benefits versus Risks
by: Suliman Al Jumaah, et al.
Published: (2012-01-01)

Expression, purification and characterization of Diacylglycerol kinase from Bacille Calmette-Guerin
by: Zih-Syuan Chen, et al.
Published: (2011)

Population differences in immune responses to Bacille Calmette-Guérin vaccination in infancy
by: Lalor, M.K, et al.
Published: (2009)

Elucidating the Efficacy of the Bacille Calmette–Guérin Vaccination in Conjunction with First Line Antibiotics and Liposomal Glutathione
by: Rachel Abrahem, et al.
Published: (2019-09-01)

Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical Bacille Calmette-Guérin
by: Sultan S Alkhateeb, et al.
Published: (2011-01-01)

Papulonecrotic tuberculid caused by Bacille Calmette-Guerin vaccination requiring no antitubercular agents
by: Kotaro Araki, et al.
Published: (2021-01-01)

The Effect of Bacille Calmette-Guérin Vaccination at Birth on Tuberculin Skin Test Reactivity
by: Iraj Sedighi, et al.
Published: (2013-12-01)

Immunotherapy of COVID-19 with Bacille Calmette – Guerin: Where is the missing red herring?
by: Hari M. Saxena
Published: (2021-03-01)

Bacille Calmette–Guérin (BCG) Vaccine Induced Tuberculous Lymphadenitis: A Case Report
by: Kalyan Sapkota
Published: (2020-12-01)

Bacille Calmette-Guérin Vaccine-Induced Tuberculous Hip Osteomyelitis in an Infant : Case report
by: Mohammed S. Al-Azri, et al.
Published: (2017-08-01)

Bacille Calmette–Guerin Complications in Newly Described Primary Immunodeficiency Diseases: 2010–2017
by: Cristiane de Jesus Nunes-Santos, et al.
Published: (2018-06-01)

Immunologic aspects of patients with disseminated bacille Calmette-Guerin disease in north-west of Iran
by: Sadeghi-Shanbestari Mahnaz, et al.
Published: (2009-12-01)

Bacille Calmette-Guérin vaccine reprograms human neonatal lipid metabolism in vivo and in vitro
by: Angelidou, A., et al.
Published: (2022)

Single course of intravesical Bacillus Calmette–Guerin versus single course with maintenance therapy in the management of nonmuscle invasive bladder cancer: A prospective randomized study
by: Mohamed Bakr Mohamed, et al.
Published: (2020-01-01)

Bacillus Calmette–Guérin and Bladder Cancer
by: Azad H.A. Razack
Published: (2007-10-01)

Mycobacterial Brain Tuberculomas due to Bacille Calmette-Guérin Intravesical Chemotherapy for Bladder Cancer: A Case Report and Literature Review
by: Vitaly Golub, et al.
Published: (2011-01-01)

Recurrence and progression in nonmuscle invasive transitional cell carcinoma of urinary bladder treated with intravesical Bacillus Calmette–Guerin: A single center experience and analysis of prognostic factors
by: Shouki N Bazarbashi, et al.
Published: (2016-01-01)

The Lack of Association Between Bacille Calmette-Guerin Vaccination and Clustering of Aboriginals with Tuberculosis in Western Canada
by: Victoria J Cook, et al.
Published: (2005-01-01)

Aerosol vaccination with Bacille Calmette-Guerin induces a trained innate immune phenotype in calves.
by: Mariana Guerra-Maupome, et al.
Published: (2019-01-01)